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Question
What is the best study design for your clinical research
question and why?
Discussion
The validity of a clinical study depends on its ability to
generate unbiased data, thereby improving the current
scientific knowledge, and to generate results that would be
applicable to the majority of patients. To achieve these
goals, rigorous scientific methods should be used in clinical
research.
When designing clinical research to address a specific
question, the first step is to establish a detailed study
design. The best and most practical study design should be
used in all cases and should minimize bias. Levels of
evidence describe the relative risks of bias for each design
[2–5], with Level I having the least risk and Level V
having the greatest risk. However, these levels are
frequently low in orthopaedic clinical research because of
specific difficulties related to this specialty and surgery in
general. We describe the most commonly used study
designs in orthopaedic surgery clinical research and show
the best ways to use them by providing practical examples.
Study Designs
When designing clinical research, the first step is to define
whether one wishes to describe or observe events or to
study a treatment or diagnostic or prognostic tool and
examine the events afterward (Table 1). This decision
divides study designs into two distinct categories:
descriptive studies and analytic studies (Fig. 1).
Descriptive Studies
Descriptive studies are those in which the researcher
merely describes a situation or some events. They offer no
explanations about the events or the type of links (ie, causal
or noncausal) between those events and potential risk
factors. However, they can give rise to hypotheses that
could be confirmed or refuted through additional studies.
Descriptive studies include cross-sectional studies, corre-
lational studies, case series, and case reports. A cross-
sectional study shows the incidence or prevalence of an
event in a specified population. An example would be the
study of the incidence of residual pain after ankle
arthroplasty. A correlational study examines potential
relations between two variables. An example would be the
study of osteoporosis prevalence and wrist fracture in men
older than 65 years. Case series typically provide a detailed
description of patients, typically more than 10. When
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describing rare diseases or rare secondary effects or com-
plications of treatments, case reports might be used; these
reports typically offer detailed descriptions of fewer than
10 patients. Findings from these latter two designs can help
generate new questions or hypotheses related to diagnostic
methods, potential risks, treatments, or associations of
diseases. They then would help the researcher justify a
future investigation with another study design and more
patients.
In case-series studies one cannot determine whether the
cases are rare or frequent (ie, their incidence). The group of
cases usually is selected and subject to bias as even rare
events may appear simultaneously without necessarily
being connected. To explore the incidence and the cause-
effect relationship while limiting as much bias as possible,
one needs analytic studies.
Analytic Studies
Analytic studies are designed to answer a scientific
hypothesis while minimizing bias as much as possible. Bias
can be minimized by using a control group or/and pro-
spective enrollment or/and randomization of patients or/
and blinding. Analytic studies include retrospective case-
control studies where a control-group is added and pro-
spective studies. Prospective studies may include no
control group (ie, longitudinal cohort studies) or one or
more groups (controlled trials) (Fig. 1).
A case-control study is a retrospective case series to
which a control group is added. As the number of patients
is increased there is a lesser chance of observing a random
result and therefore is prone to less bias than a study
without such a control group. For example, a group of
patients who experienced one episode of dislocation
of their THA prosthesis could be compared with a group of
patients in whom the hip prosthesis did not dislocate and
who had their surgery performed during the same period to
determine factors related to the presence of dislocation.
Without controls, the real effect of potential factors could
not be identified conclusively because they could be pres-
ent in subjects who did not experience dislocation.
A matched-paired case-control study further reduces the
risk of bias of a retrospective case-control study design by
matching each patient with a control patient by presumed
confounding factors. Confounding factors, such as age,
gender, and comorbidities, have the potential to influence
outcome if they do not occur in the same proportions in
both groups. The best control for the patient would be him-
or herself. If the patient can be studied with two distinct
treatments at different times, the study then is called a
crossover case-control study. This design would be possi-
ble only if the baseline status of the patients can be
measured before observing them in a second situation.
However, even if some bias can be avoided, case-control
studies remain retrospective designs and, as such, may give
rise to time-related biases. For example, (1) with time the
patient could have an imperfect memory of the symptoms
Fig. 1 The available study
designs and categories are
shown.
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before and after the event or could interpret the event with
time therefore giving more or less emphasis on one or the
other symptoms he/she had before or after the event; (2)
with time the treatments and/or assessments and/or record
keeping might have been more or less subtly changed.
A longitudinal cohort study is a prospective study in
which one group of patients is followed longitudinally
while the baseline parameters and their evolution are
recorded. The measurement tools are chosen before the
patients are included in the study. For example, one could
study quality of life and ROM of the knee in patients before
and after TKA using the WOMAC questionnaire and an
ambulatory gait analysis device. However, in this pro-
spective design, there is still a potential selection bias:
investigators can choose which patients to enroll unless all
patients with a given diagnosis are included (ie, a con-
secutive series). Even if all patients are included, there still
can be other forms of bias such as referral bias (in which
the patients are limited to those seeking care at a given
institution or institutions) or diagnostic bias (in which
specific criteria are required for diagnosis but potentially
excluded other patients).
A triple randomized clinical trial (RCT) of sufficient
sample size, where the randomization assignment has been
followed, is considered the gold standard design for clinical
research because randomization remains the only way to
minimize selection bias: the control of all potential con-
founding factors is enhanced and, given adequate power,
even unknown factors will be distributed more equally
between the two groups of patients under study. For
example, this avoids selection of younger and healthier
patients for a new type of implant, or more compliant
patients for the treatment with possible increased side
effects. The randomization should remain coded and not
determined by a simple method such as an alternative
process (ie, ABABA). Randomization may be performed
by blocks and stratification to improve the allocation pro-
cedure: it then achieves an approximate balance of
important characteristics especially in small studies (age
distribution for example) [1].
To avoid systematic subjectivity and treatment bias,
blinding to knowledge of the treatment should be added
when possible. If a patient, surgeon, or observer knows that
a specific treatment is available, he or she probably will act
differently. Patients might have better care from the sur-
geons’ preferred treatment modality. Surgeons could make
different decisions with respect to whether to stop the study
for a patient because of his or her generally poor medical
condition when knowing the treatment group (attrition
bias). Researchers might evaluate the patients differently
(radiographic measurement, side effects, etc) if they think
one treatment is not as effective as another (assessment
bias). Blinding therefore is particularly important if
possible, and would best apply to patients, surgeons,
observers, and/or statisticians. A study can be single-,
double-, or triple-blind depending on the people involved.
A single-blind study would have only the patient, or the
surgeon, or the researcher blinded; that is, one of these
three categories of people would be blinded, while the
other two would not be, often because it simply is not
possible or ethical. If two of these categories could be
blinded, then the study would be a double-blind study. If all
these three categories could be blinded, then the study
would be triple-blind. Blinding should be maintained until
the end of the study (after statistical analysis) to achieve
the best level of confidence in the data recorded. Studies
without randomization or low blinding have been described
as having more therapeutic effects than double-blind ran-
domized controlled clinical trials [6]. Triple-blind
randomized controlled trials therefore provide the highest
level of reliable evidence. However, additional analysis of
residual confounding should be performed during data
analysis to ensure the full validity of the study findings [7].
Systematic reviews, meta-analysis studies, and decision
analysis studies are based on previous publications of a
specific topic and allow more global views if properly
conducted. The conclusions of these studies rely on the
quality and availability of data, more than the design.
Myths and Misconceptions
A RCT is not always better than a retrospective study: if a
RCT is not blinded, has a small sample size, or has many
protocol violations, the quality of the study will be low.
Matching of patients in retrospective case-control studies
does not always reduce bias if the control group is not
properly selected and matched to the appropriate charac-
teristics of the populations. Repeated measurements on
subjects do not increase the number of independent
observations.
Conclusion
After formulating an addressable question, the first step in
designing a study is to determine how one might minimize
the various forms of bias. The randomized, controlled,
triple-blind study generally is identified as the gold stan-
dard. If this design is the most reliable and objective
method to eliminate bias and produce solid evidence, it
also is far from always being practical in orthopaedic
clinical research. Even though levels of evidence reflect
potential for bias, these levels per se should not be at the
forefront of one’s mind when designing a study. Rather,
one should think about minimizing bias: (1) whether there
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are controls, (2) whether there is blinding of the treatment
to patients, and/or observers, and (3) the randomization
process. Ethical considerations and the individual skill and
technique of the surgeons often dictate the choices that are
made. The case report that informs surgeons about a rare
but devastating complication is still essential. All study
designs are useful. The best study design therefore is the
one that could provide the best evidence to answer the
research question.
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